US Stock MarketDetailed Quotes

PRME Prime Medicine

Watchlist
  • 3.345
  • +0.145+4.53%
Trading Nov 25 13:54 ET
438.73MMarket Cap-1623P/E (TTM)

Prime Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Prime Medicine Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.750M--
--2024/Q4-- / 287.500K--
--2024/Q30.000 / 7.118M--
--2024/Q20.000 / 1.358M--
--2024/Q1591.000K / 912.500K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.750M--
--2024/Q4-- / 287.500K--
--2024/Q30.000 / 7.118M--
--2024/Q20.000 / 1.358M--
--2024/Q1591.000K / 912.500K--

Unlock Free Earnings Estimates

Prime Medicine Earnings Reports

  • Prime Medicine | 8-K: Prime Medicine Reports Third Quarter 2024 Financial Results and Provides Business Updates

    Nov 12 16:55 ET

  • Prime Medicine | 10-Q: Q3 2024 Earnings Report

    Nov 12 16:16 ET

  • Prime Medicine | 10-Q: Q2 2024 Earnings Report

    Aug 8 08:29 ET

  • Prime Medicine | 8-K: Prime Medicine Reports Second Quarter 2024 Financial Results and Provides Business Updates

    Aug 8 08:14 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 13, 2024

    Buy

    • Buy

      71.43%

    • Hold

      28.57%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data